Functional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1

Journal of Virology

Volumn 83, Issue 21, 2009, Pages 11116-11122

  Bailey, Sarah G ^a   Verrall, Elizabeth ^a   Schelcher, Celine ^a   Rhie, Alex ^b   Doherty, Aidan J ^b   Sinclair, Alison J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; IMMEDIATE EARLY PROTEIN BZLF1; NUCLEAR PROTEIN; PROTEIN 53BP1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA BINDING; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS REPLICATION; WILD TYPE;

BRCA1 PROTEIN; CELL CYCLE PROTEINS; CELL LINE; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

EID: 70350314472     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00512-09     Document Type: Article

References (64)

1. Adamson, A. L., and S. Kenney. 1999. The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J. Virol. 73:6551-6558.
2. Asai, R., A. Kato, K. Kato, M. Kanamori-Koyama, K. Sugimoto, T. Sairenji, Y. Nishiyama, and Y. Kawaguchi. 2006. Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. J. Virol. 80:5125-5134. (Pubitemid 43752758)
3. Baumann, M., O. Gires, W. Kolch, H. Mischak, R. Zeidler, D. Pich, and W. Hammerschmidt. 2000. The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1. Eur. J. Biochem. 267:3891-3901.
4. Biggin, M., M. Bodescot, M. Perricaudet, and P. Farrell. 1987. Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J. Virol. 61:3120-3132. (Pubitemid 17131493)
5. Bork, P., K. Hofmann, P. Bucher, A. F. Neuwald, S. F. Altschul, and E. V. Koonin. 1997. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:68-76. (Pubitemid 27076326)
6. Cayrol, C., and E. Flemington. 1996. G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J. Biol. Chem. 271:31799-31802.
7. Cayrol, C., and E. K. Flemington. 1996. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15:2748-2759. (Pubitemid 26176252)
8. Daikoku, T., A. Kudoh, M. Fujita, Y. Sugaya, H. Isomura, N. Shirata, and T. Tsurumi. 2005. Architecture of replication compartments formed during Epstein-Barr virus lytic replication. J. Virol. 79:3409-3418. (Pubitemid 40327929)
9. Derbyshire, D. J., B. P. Basu, L. C. Serpell, W. S. Joo, T. Date, K. Iwabuchi, and A. J. Doherty. 2002. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 21:3863-3872.
10. Feederle, R., M. Kost, M. Baumann, A. Janz, E. Drouet, W. Hammerschmidt, and H. J. Delecluse. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19:3080-3089. (Pubitemid 30386778)
11. Flemington, E. K. 2001. Herpesvirus lytic replication and the cell cycle: arresting new developments. J. Virol. 75:4475-4481.
12. Gallagher, A., A. A. Armstrong, J. MacKenzie, L. Shield, G. Khan, A. Lake, S. Proctor, P. Taylor, G. B. Clements, and R. F. Jarrett. 1999. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int. J. Cancer 84:442-448. (Pubitemid 29337135)
13. Gershburg, E., S. Raffa, M. R. Torrisi, and J. S. Pagano. 2007. Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J. Virol. 81:5407-5412. (Pubitemid 46744449)
14. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
15. Grunewald, V., M. Bonnet, S. Boutin, T. Yip, H. Louzir, M. Levrero, J. M. Seigneurin, M. Raphael, R. Touitou, D. Martel-Renoir, C. Cochet, A. Durandy, P. Andre, W. Lau, Y. Zeng, and I. Joab. 1998. Amino-acid change in the Epstein-Barr virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa. Int. J. Cancer 75:497-503. (Pubitemid 28094092)
16. Hicks, M. R., S. S. Al-Mehairi, and A. J. Sinclair. 2003. The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding. J. Virol. 77:8173-8177.
17. Hicks, M. R., S. Balesaria, C. Medina-Palazon, M. J. Pandya, D. N. Woolfson, and A. J. Sinclair. 2001. Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. J. Virol. 75:5381-5384.
18. Iwabuchi, K., P. L. Bartel, B. Li, R. Marraccino, and S. Fields. 1994. Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. USA 91:6098-6102.
19. Iwabuchi, K., B. P. Basu, B. Kysela, T. Kurihara, M. Shibata, D. Guan, Y. Cao, T. Hamada, K. Imamura, P. A. Jeggo, T. Date, and A. J. Doherty. 2003. Potential role for 53BP1 in DNA end-joining repair through direct interaction with DNA. J. Biol. Chem. 278:36487-36495.
20. Jeggo, P. A., and M. Lobrich. 2006. Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability. DNA Repair (Amsterdam) 5:1192-1198. (Pubitemid 44308466)
21. Ji, K. M., C. L. Li, G. Meng, A. D. Han, and X. L. Wu. 2008. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China. Arch. Virol. 153:1949-1953.
22. Joo, W. S., P. D. Jeffrey, S. B. Cantor, M. S. Finnin, D. M. Livingston, and N. P. Pavletich. 2002. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16:583-593. (Pubitemid 34212491)
23. Kudoh, A., M. Fujita, L. Zhang, N. Shirata, T. Daikoku, Y. Sugaya, H. Isomura, Y. Nishiyama, and T. Tsurumi. 2005. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an Sphase-like cellular environment. J. Biol. Chem. 280:8156-8163.
24. Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1988. The leucine zipper protein: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759-1764.
25. Lilley, C. E., R. A. Schwartz, and M. D. Weitzman. 2007. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 15:119-126. (Pubitemid 46356979)
26. Löbrich, M., and P. A. Jeggo. 2005. The two edges of the ATM sword: co-operation between repair and checkpoint functions. Radiother. Oncol. 76:112-118.
27. Macsween, K. F., and D. H. Crawford. 2003. Epstein-Barr virus - recent advances. Lancet Infect. Dis. 3:131-140.
28. Manke, I. A., D. M. Lowery, A. Nguyen, and M. B. Yaffe. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302:636-639.
29. 2 and a mitotic block. J. Virol. 76:10030-10037.
30. Mauser, A., E. Holley-Guthrie, A. Zanation, W. Yarborough, W. Kaufmann, A. Klingelhutz, W. T. Seaman, and S. Kenney. 2002. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J. Virol. 76:12543-12552.
31. Mauser, A., S. Saito, E. Appella, C. W. Anderson, W. T. Seaman, and S. Kenney. 2002. The Epstein-Barr Virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 76:12503-12512. (Pubitemid 35386936)
32. McDonald, C. M., C. Petosa, and P. J. Farrell. 2009. Interaction of Epstein-Barr virus BZLF1 C-terminal tail structure and core zipper is required for DNA replication but not for promoter transactivation. J. Virol. 83:3397-3401.
33. Mikaélian, I., E. Drouet, V. Marechal, G. Denoyel, J. C. Nicolas, and A. Sergeant. 1993. The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence. J. Virol. 67:734-742. (Pubitemid 23032050)
34. Miller, G., A. El-Guindy, J. Countryman, J. Ye, and L. Gradoville. 2007. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv. Cancer Res. 97:81-109.
35. Morand, P., M. Budayova-Spano, M. Perrissin, C. W. Muller, and C. Petosa. 2006. Expression, purification, crystallization and preliminary X-ray analysis of a C-terminal fragment of the Epstein-Barr virus ZEBRA protein. Acta Crystallogr. F Struct. Biol. Cryst. Commun. 62:210-214.
36. Morrison, T. E., and S. C. Kenney. 2004. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function. Virology 328:219-232.
37. Morrison, T. E., A. Mauser, A. Klingelhutz, and S. C. Kenney. 2004. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. J. Virol. 78:544-549.
38. Petosa, C., P. Morand, F. Baudin, M. Moulin, J. B. Artero, and C. W. Muller. 2006. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol. Cell 21:565-572. (Pubitemid 43228011)
39. Prang, N. S., M. W. Hornef, M. Jager, H. J. Wagner, H. Wolf, and F. M. Schwarzmann. 1997. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665-1677.
40. Puig, O., F. Caspary, G. Rigaut, B. Rutz, E. Bouveret, E. Bragado-Nilsson, M. Wilm, and B. Seraphin. 2001. The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods 24:218-229. (Pubitemid 32846428)
41. Rigaut, G., A. Shevchenko, B. Rutz, M. Wilm, M. Mann, and B. Seraphin. 1999. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17:1030-1032.
42. Rodriguez, A., M. Armstrong, D. Dwyer, and E. Flemington. 1999. Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J. Virol. 73:9029-9038. (Pubitemid 29487056)
43. Rodriguez, A., E. J. Jung, Q. Yin, C. Cayrol, and E. K. Flemington. 2001. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 284:159-169. (Pubitemid 32523218)
44. Schelcher, C., S. Al Mehairi, E. Verrall, Q. Hope, K. Flower, B. Bromley, D. N. Woolfson, M. J. West, and A. J. Sinclair. 2007. Atypical bZIP domain of viral transcription factor contributes to stability of dimer formation and transcriptional function. J. Virol. 81:7149-7155. (Pubitemid 46986650)
45. Schelcher, C., S. Valencia, H. J. Delecluse, M. Hicks, and A. J. Sinclair. 2005. Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency. J. Virol. 79:13822-13828.
46. Schepers, A., D. Pich, and W. Hammerschmidt. 1996. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220:367-376. (Pubitemid 26201693)
47. Schepers, A., D. Pich, and W. Hammerschmidt. 1993. A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J. 12:3921-3929. (Pubitemid 23282768)
48. Sinclair, A., S. Yarranton, and C. Schelcher. 2006. DNA-damage response pathways triggered by viral replication. Expert Rev. Mol. Med. 8:1-11.
49. Sinclair, A. J. 2003. bZIP proteins of human gamma herpesviruses. J. Gen. Virol. 84:1941-1949.
50. Sinclair, A. J. 2006. Unexpected structure of Epstein-Barr virus lytic cycle activator Zta. Trends Microbiol. 14:289-291. (Pubitemid 43963362)
51. Sinclair, A. J., M. Brimmell, F. Shanahan, and P. J. Farrell. 1991. Pathways of activation of the Epstein-Barr virus productive cycle. J. Virol. 65:2237-2244.
52. Sista, N. D., C. Barry, K. Sampson, and J. Pagano. 1995. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha. Nucleic Acids Res. 23:1729-1736.
53. Talbot, S. J., and D. H. Crawford. 2004. Viruses and tumours - an update. Eur. J. Cancer 40:1998-2005.
54. Tarakanova, V. L., V. Leung-Pineda, S. Hwang, C. W. Yang, K. Matatall, M. Basson, R. Sun, H. Piwnica-Worms, B. P. Sleckman, and H. W. T. Virgin. 2007. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1:275-286.
55. Tsurumi, T., M. Fujita, and A. Kudoh. 2005. Latent and lytic Epstein-Barr virus replication strategies. Rev. Med. Virol. 15:3-15.
56. Wang, J. T., P. W. Yang, C. P. Lee, C. H. Han, C. H. Tsai, and M. R. Chen. 2005. Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol. 86:3215-3225.
57. Weitzman, M. D., C. T. Carson, R. A. Schwartz, and C. E. Lilley. 2004. Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amsterdam) 3:1165-1173. (Pubitemid 38997960)
58. Wiedmer, A., P. Wang, J. Zhou, A. J. Rennekamp, V. Tiranti, M. Zeviani, and P. M. Lieberman. 2008. Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication. J. Virol. 82:4647-4655. (Pubitemid 351563701)
59. Xie, A., and R. Scully. 2007. Hijacking the DNA damage response to enhance viral replication: gamma-herpesvirus 68 orf36 phosphorylates histone H2AX. Mol. Cell 27:178-179. (Pubitemid 47058313)
60. Young, L. S., R. Lau, M. Rowe, G. Niedobitek, G. Packham, F. Shanahan, D. T. Rowe, D. Greenspan, J. S. Greenspan, A. B. Rickinson, et al. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:2868-2874.
61. Zerby, D., C. J. Chen, E. Poon, D. Lee, R. Shiekhattar, and P. M. Lieberman. 1999. The amino-terminal C/H1 domain of CREB binding protein mediates Zta transcriptional activation of latent Epstein-Barr virus. Mol. Cell. Biol. 19:1617-1626.
62. Zhang, L., J. L. Chiu, and J. C. Lin. 1998. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent. DNA Cell Biol. 17:735-742. (Pubitemid 28462872)
63. Zhang, Q., D. Gutsch, and S. Kenney. 1994. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14:1929-1938.
64. zur Hausen, H., G. W. Bornkamm, R. Schmidt, and E. Hecker. 1979. Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 76:782-785.